Materias dentro de su búsqueda.
Mostrando 1,921 - 1,940 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.25s Limitar resultados
  1. 1921
    “…BACKGROUND: Follow-up assessment of visceral leishmaniasis (VL) treated cases is important to monitor the long term effectiveness of treatment regimens. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Follow-up assessment of visceral leishmaniasis treated patients and the impact of COVID-19 on control services in Nepal
  2. 1922
    “…BACKGROUND: Control of leishmaniasis in the Mediterranean Basin relies on the active contributions from researchers in the fields of animal, human and environmental health. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Knowledge, perceptions and practices of health students and professionals regarding leishmaniasis in Portugal: a cross-sectional study
  3. 1923
    “…INTRODUCTION: Visceral leishmaniasis (VL) is a neglected tropical disease responsible for many thousands of preventable deaths each year. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review
  4. 1924
    “…BACKGROUND: A cohort study for 2 years period analysed the prevalence, incidence and clinical–immunological features of canine Leishmania (L.) chagasi‐infection in 316 mongrel dogs in a visceral leishmaniasis‐endemic area in Pará State, Brazil. OBJECTIVE/METHODS: Diagnosis of infection was performed by the indirect fluorescent antibody test (IFAT‐IgG), the leishmanin skin test (LST) and a parasite search (from the popliteal lymph node aspiration) at the beginning of the study and at 6, 12 and 24 months intervals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevalence and incidence of canine visceral leishmaniasis and its clinical–immunological features in an endemic area of the Brazilian Amazon
  5. 1925
    “…INTRODUCTION: Cutaneous leishmaniasis (CL) is a prevalent debilitating disease in many countries, particularly in Iran, the Middle East, North Africa, and South America. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Geographical and climatic risk factors of cutaneous leishmaniasis in the hyper-endemic focus of Bam County in southeast Iran
  6. 1926
    Publicado 1993
    Enlace del recurso
    Enlace del recurso
    Texto
    Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response
  7. 1927
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Role for CD4(+) CD25(+) Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity
  8. 1928
    “…This study aimed to investigate, describe, and analyse international media coverage of “neglected diseases” in general and three specific NTDs—African trypanosomiasis, leishmaniasis, and Chagas disease—from 1 January 2003 to 1 June 2007. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Neglected Diseases in the News: A Content Analysis of Recent International Media Coverage Focussing on Leishmaniasis and Trypanosomiasis
  9. 1929
    “…The data presented here show changes in the white pulp of the spleen that are associated with naturally acquired visceral leishmaniasis.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Inflammation and structural changes of splenic lymphoid tissue in visceral leishmaniasis: A study on naturally infected dogs
  10. 1930
    “…OBJECTIVE: We sought to estimate visceral leishmaniasis (VL) burden in Bangladesh, India, and Nepal and document care-seeking behaviour for VL to provide baseline information for monitoring the VL elimination program and identify options for improved case finding and management. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Visceral Leishmaniasis Elimination Programme in India, Bangladesh, and Nepal: Reshaping the Case Finding/Case Management Strategy
  11. 1931
    por Bhowmick, Sudipta, Ali, Nahid
    Publicado 2009
    “…Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani is a major public health problem in the developing world. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis
  12. 1932
    “…BACKGROUND: Current strategies for controlling American visceral leishmaniasis (AVL) have been unable to prevent the spread of the disease across Brazil. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Synthetic sex pheromone attracts the leishmaniasis vector Lutzomyia longipalpis to experimental chicken sheds treated with insecticide
  13. 1933
    “…BACKGROUND: Risk factors associated with L. donovani visceral leishmaniasis (VL; kala azar) relapse are poorly characterized. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Visceral Leishmaniasis Relapse in Southern Sudan (1999–2007): A Retrospective Study of Risk Factors and Trends
  14. 1934
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Visceral Leishmaniasis in Far Western Nepal: Another Case and Concerns about a New Area of Endemicity
  15. 1935
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Toolkit for Monitoring and Evaluation of Indoor Residual Spraying for Visceral Leishmaniasis Control in the Indian Subcontinent: Application and Results
  16. 1936
    “…Topical treatment of cutaneous leishmaniasis is an attractive alternative avoiding toxicities of parenteral therapy while being administered through a simple painless route. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
  17. 1937
    “…BACKGROUND: Leishmania major complex is the main causative agent of zoonotic cutaneous leishmaniasis (ZCL) in the Old World. Phlebotomus papatasi and Phlebotomus duboscqi are recognized vectors of L. major complex in Northern and Southern Sahara, respectively. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    First Detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from Cutaneous Leishmaniasis Foci in Mali
  18. 1938
    “…BACKGROUND: New cases of visceral leishmaniasis (VL) have been reported recently in some parts of Mazandaran Province, north of Iran where the first human case of VL was reported in 1949. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molecular and Seroepidemiological Survey of Visceral Leishmaniasis among Humans and Domestic Dogs in Mazandaran Province, North of Iran
  19. 1939
    “…Leishmania infantum is the etiologic agent of visceral leishmaniasis (VL) in the Americas, Mediterranean basin and West and Central Asia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Genetic Structure of Leishmania infantum Populations in Brazil and Its Possible Association with the Transmission Cycle of Visceral Leishmaniasis
  20. 1940
    “…BACKGROUND: Human visceral leishmaniasis (VL), a potentially fatal disease, has emerged as an important opportunistic condition in HIV infected patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Diagnostic Accuracy of Serologic and Molecular Methods for Detecting Visceral Leishmaniasis in HIV Infected Patients: Meta-Analysis
Herramientas de búsqueda: RSS